CCRDF(CCRDF)
CCRDF
No analyst ratings available
No analyst price targets available for CCRDF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|
| Revenue Avg | $390.75B | $429.19B | $458.72B | $337.21B |
| Low | $382.64B | $395.88B | $435.55B | $320.18B |
| High | $404.65B | $461.77B | $484.73B | $356.33B |
| EBITDA Avg | $130.02B | $142.81B | $152.64B | $112.21B |
| Low | $127.32B | $131.73B | $144.93B | $106.54B |
| High | $134.65B | $153.65B | $161.29B | $118.57B |
| EBIT Avg | $114.43B | $125.68B | $134.33B | $98.75B |
| Low | $112.05B | $115.93B | $127.54B | $93.76B |
| High | $118.50B | $135.23B | $141.95B | $104.35B |
| Net Income Avg | $855M | $999M | $1.09B | $946M |
| Low | $799M | $933M | $1.02B | $884M |
| High | $918M | $1.07B | $1.17B | $1.02B |
| EPS Avg | $119.83 | $140.02 | $152.70 | $132.59 |
| Low | $111.96 | $130.83 | $142.67 | $123.88 |
| High | $128.66 | $150.34 | $163.95 | $142.36 |
| Analysts (Rev / EPS) | 4 / 1 | 4 / 1 | 3 / 1 | 3 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $94.70B | $87.95B | $92.46B | $104.01B | $108.61B | $104.55B | $109.53B | $120.33B |
| Low | $93.34B | $86.68B | $91.13B | $102.51B | $107.05B | $103.04B | $107.96B | $118.60B |
| High | $96.06B | $89.21B | $93.79B | $105.50B | $110.17B | $106.05B | $111.11B | $122.06B |
| EBITDA Avg | $31.51B | $29.26B | $30.77B | $34.61B | $36.14B | $34.79B | $36.45B | $40.04B |
| Low | $31.06B | $28.84B | $30.32B | $34.11B | $35.62B | $34.29B | $35.92B | $39.46B |
| High | $31.96B | $29.69B | $31.21B | $35.11B | $36.66B | $35.29B | $36.97B | $40.62B |
| EBIT Avg | $27.73B | $25.75B | $27.08B | $30.46B | $31.81B | $30.62B | $32.08B | $35.24B |
| Low | $27.33B | $25.38B | $26.69B | $30.02B | $31.35B | $30.18B | $31.61B | $34.73B |
| High | $28.13B | $26.13B | $27.47B | $30.90B | $32.26B | $31.06B | $32.54B | $35.74B |
| Net Income Avg | $34.69B | $31.70B | $31.86B | $37.03B | $39.24B | $37.16B | $38.40B | $43.90B |
| Low | $34.04B | $31.11B | $31.26B | $36.34B | $38.50B | $36.47B | $37.68B | $43.08B |
| High | $35.34B | $32.29B | $32.45B | $37.72B | $39.97B | $37.86B | $39.12B | $44.72B |
| EPS Avg | $31.10 | $28.43 | $28.57 | $33.20 | $35.18 | $33.32 | $34.43 | $39.36 |
| Low | $30.52 | $27.89 | $28.03 | $32.58 | $34.52 | $32.70 | $33.79 | $38.63 |
| High | $31.69 | $28.96 | $29.10 | $33.82 | $35.84 | $33.95 | $35.08 | $40.10 |
| Analysts (Rev / EPS) | 2 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |